Fellowship ​

Professor Markus Seibel has been an international leader in musculoskeletal medicine for over 25 years. Covering basic, translational and clinical research, Markus has made seminal contributions to the area of skeletal physiology and pathophysiology as well as clinical management of osteoporosis. He has published over 400 scientific articles and edited six academic books. His work has been highly influential being cited >12,000 times. He is Immediate Past-President of the Australian and New Zealand Bone & Mineral Society, Chair of the National Fracture Prevention Alliance and is a Director of the International Federation of Musculoskeletal Research Societies.

Professor Jeffrey Braithwaite, Foundation Director of the Australian Institute of Health Innovation, and Professor of Health Systems Research, Faculty of Medicine and Health Sciences, Macquarie University researches the way care is delivered to patients and how it can be improved. He has contributed over 700 total publications and presented at international and national conferences on more than 800 occasions, including 80 keynote addresses. His research appears in journals such as British Medical Journal, The Lancet, Social Science & Medicine, and BMJ Quality and Safety. He has received numerous national and international awards for his teaching and research.

Professor Maher is a renowned public health scientist who applies both epidemiological and anthropological approaches to important public health problems – in particular hepatitis C virus (HCV) infection –  including leading the first ever HCV vaccine preparedness study. Her high standing is evidenced by extensive conference invitations as well as an outstanding record of competitive grant funding. This is matched by the respect she enjoys in the wider community, as evidenced by invitations to join high level policy and advisory committees, including the WHO Strategic and Technical Advisory Committee on Viral Hepatitis. She would be a most influential addition to the Fellowship.

Professor Andrew Lloyd AM is a distinguished infectious diseases physician scientist. He has made major contributions to clinical practice in hepatitis C infection (particularly amongst the prisoner population) and also in chronic fatigue states associated with infection and cancer. He has also made major contributions in laboratory-based studies of the pathophysiology of hepatitis C infection, the acute sickness response to infection and post-infective fatigue states. These studies have led the research direction internationally as well as delivered important clinical practice innovations in Australia. Professor Lloyd has also contributed extensively in research leadership, particularly in the field of viral hepatitis.

Professor Scolyer leads one of world’s largest histopathology consultation practices and is widely regarded as the Australasian point of reference for diagnosis of difficult pigmented skin lesions. He co-leads an award winning translational research program investigating causes, prognostic /predictive biomarkers and treatment of melanoma. He has authored >450 peer-reviewed journal publications (>14,000 citations), and according to Thomson ISI, is the highest ever published scientist worldwide in the field of melanoma pathology and also has highest H index in this field. Professor Scolyer was independently ranked world’s leading melanoma pathologist on multiple occasions. He holds leadership roles in the WHO and AJCC.